LGND
LigandBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Current thesis
The bull case is that Q1 preserved the bigger thesis despite the headline miss: royalty revenue still grew 56% year over year, Filspari received full FDA approval in FSGS and was called Ligand's largest royalty contributor, cash and investments rose to $779.4 million at March 31, 2026, and management reaffirmed the previously raised 2026 guidance tied to XOMA [#8-K-2026-05-07].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +8.1.
What can break
Ligand remains dependent on partners for regulatory approvals, launch execution, sales conversion, and milestone timing across the royalty portfolio.
Momentum
72
Value
58
Sentiment
42
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $228.00 · Bull $255.00 · Bear $180.00
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $244.56
Why
Momentum72 · Δ7d +8.1
Value58 · Δ7d +0.1
Sentiment42 · Δ7d +1.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
72
34% active weight
Current posture
7d trendFlat
Δ7d
+8.1
Δ21d
+2.4
Value
58
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.3
Sentiment
42
33% active weight
Current posture
7d trendImproving
Δ7d
+1.7
Δ21d
+2.1
Why this grade
Composite grade B. Momentum 71.8 / Value 58.1 / Sentiment 42.1
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$4.66B
Beta
1.20
Shares Out
19.68M
P/E (TTM)
92.4
P/S (TTM)
15.04
P/FCF (TTM)
122.87
Rev YoY
+122.8%
EPS YoY
+1560.0%
Gross Margin
+94.3%
Op Margin
+7.0%
Net Debt
-$256.14M
Current Ratio
24.69
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology